A Pharmacokinetic and Safety Study of IV Gallium Nitrate (Ganite) in Cystic Fibrosis Patients
Status:
Completed
Trial end date:
2013-08-31
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to test the pharmacokinetics, safety, and tolerability
of an intravenous infusion of a drug called Ganite (gallium nitrate) in patients with cystic
fibrosis. We want to see this drug is safe and tolerable and to see if high levels of the
drug are found in the sputum.
Funding Source - Food and Drug Administration (FDA) Office of Orphan Products Development
(OOPD)
Phase:
Phase 1
Details
Lead Sponsor:
University of Washington
Collaborators:
Cystic Fibrosis Foundation Cystic Fibrosis Foundation Therapeutics